MyLeukemiaTeam

Does the Pegasys 135 injection affect the liver?

Pegasys (pegylated interferon alfa-2a) is used to treat certain types of leukemia, including chronic myeloid leukemia (CML) and hairy cell leukemia (HCL). It is a pegylated form of interferon, meaning it stays in the blood longer and often requires lower doses compared to Show Full Answer

Does the Pegasys 135 injection affect the liver?

Pegasys (pegylated interferon alfa-2a) is used to treat certain types of leukemia, including chronic myeloid leukemia (CML) and hairy cell leukemia (HCL). It is a pegylated form of interferon, meaning it stays in the blood longer and often requires lower doses compared to older interferon treatments.

Pegasys can potentially affect the liver. Some known considerations include:

- Liver enzyme levels may rise during treatment, which your doctor will likely monitor through regular blood tests
- It's important to report any symptoms like yellowing of the skin or eyes, dark urine, or unusual fatigue to your doctor promptly
- Your healthcare team should be checking liver function regularly while you're on this medication

These effects vary from person to person, and not everyone experiences liver-related issues. The key is staying on top of your regular monitoring appointments so any changes can be caught early.

Always speak with your doctor or pharmacist if you have specific concerns about how Pegasys may be affecting your liver — they can review your individual bloodwork and give the most personalized guidance.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Interferon Therapy for Leukemia: When Is It Used?